top of page
Biosciences
Offspring
Insights & Updates
Surviving the Phase II Cliff: Why So Many Promising Drugs Fail — and What We Can Do About It
For translational leaders, generating decision-quality data before risking millions in clinical trials is crucial. De-Risk Antibody Development with Tissue Insights Platform.
Featured
Search
The Validation Gauntlet: Multi-Modal Framework for Fit-for-Purpose IHC
A detailed examination of the technical pillars of assay validation, from tissue integrity screening and antibody selection to antibody validation with ISH and isPLA
evadanielson55
Apr 285 min read
bottom of page